The role of apurinic/apyrimidinic endonuclease on the progression of streptozotocin-induced diabetic nephropathy in rats

Acta Histochemica

Volumn 114, Issue 7, 2012, Pages 647-652

  Kim, Jin Nam ^a   Chang, In Youb ^b   Kim, Jin Hwa ^b   Kim, Jung Woo ^c   Park, Kyeong Soo ^c   Kim, Hyun Il ^d   Yoon, Sang Pil ^e  

^a Inje University College of Medicine   (South Korea)

^b Chosun University   (South Korea)

^c Seonam University   (South Korea)

^d Eulji University   (South Korea)

^e Jeju National University School of Medicine   (South Korea)

Author keywords

APE; Apoptosis; Chitosan oligosaccharide; Diabetes; Kidney; P53; Rat

Indexed keywords

ANTIOXIDANT; CASPASE 3; CHITOSAN; CHITOSAN OLIGOSACCHARIDE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; PROTEIN P53; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY SIZE; MALE; NONHUMAN; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BLOOD UREA NITROGEN; CASPASE 3; CHITOSAN; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DNA DAMAGE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ENZYME ACTIVATORS; MALE; NEPHRONS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 84863497963     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.11.011     Document Type: Article

References (35)

1. Allen D.A., Yaqoob M.M., Harwood S.M. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005, 16:705-713.
2. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002, 511:145-178.
3. Brownlee M. Preventing kidney cell suicide. Nat Med 2007, 13:1284-1285.
4. Carey R.M., Siragy H.M. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003, 14:274-281.
5. Chang I.Y., Kim J.N., Jun J.Y., You H.J., Jeon Y.J., Park K.S., et al. Repression of apurinic/apyrimidinic endonuclease by p53-dependent apoptosis in hydronephrosis-induced rat kidney. Free Radic Res 2011, 45:728-734.
6. Chipuk J.E., Bouchier-Hayes L., Kuwana T., Newmeyer D.D., Green D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309:1732-1735.
7. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
8. Fuchs S., Philippe J., Corvol P., Pinet F. Implication of Ref-1 in the repression of rennin gene transcription by intracellular calcium. J Hypertens 2003, 21:327-335.
9. Hase M., Babazono T., Karibe S., Kinae N., Iwamoto Y. Renoprotective effects of tea catechin in streptozotocin-induced diabetic rats. Int Urol Nephrol 2006, 38:693-699.
10. Huang R., Mendis E., Kim S.K. Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification. Bioorg Med Chem 2005, 13:3649-3655.
11. Imaeda A., Kaneko T., Aoki T., Kondo Y., Nagase H. DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol 2002, 40:979-987.
12. Jiang M., Wei Q., Pabla N., Dong G., Wang C.Y., Yang T., et al. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 2007, 73:1499-1510.
13. Jiang M., Dong Z. Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther 2008, 327:300-307.
14. Kim J.N., Chang I.Y., Kim H.I., Yoon S.P. Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic rats. Islets 2009, 1:111-116.
15. Kraynak A.R., Storer R.D., Jensen R.D., Kloss M.W., Soper K.A., Clair J.H., et al. Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vitro alkaline elution and BrdU labeling assays. Toxicol Appl Pharmacol 1995, 135:279-286.
16. Ku Y.P., Jin M., Kim K.H., Ahn Y.J., Yoon S.P., You H.J., et al. Immunolocalization of 8-OHdG and OGG1 in pancreatic islets of streptozotocin-induced diabetic rats. Acta Histochem 2009, 111:138-144.
17. Lee H.W., Park Y.S., Choi J.W., Yi S.Y., Shin W.S. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol Pharm Bull 2003, 26:1100-1103.
18. Liu B., Liu W.S., Han B.Q., Sun Y.Y. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World J Gastroenterol 2007, 13:725-731.
19. Liu Z., Li J., Zeng Z., Liu M., Wang M. The anti-diabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozotocin-induced diabetic rats. Chem Biol Interact 2008, 173:68-75.
20. Park P.J., Je J.Y., Kim S.K., Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans. J Agric Food Chem 2003, 51:4930-4934.
21. Park P.J., Ahn C.B., Jeon Y.J., Je J.Y. Renin inhibition activity by chitooligosaccharides. Bioorg Med Chem Lett 2008, 18:2471-2474.
22. Singh R., Singh A.K., Leehey D.J. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 2005, 288:F1183-F1190.
23. Singh D.K., Winocour P., Farrington K. Mechanisms of disease; the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 2008, 4:216-226.
24. Sun H.L., Sun L., Li Y.Y., Shao M.M., Cheng X.Y., Ge N., et al. ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats. Exp Clin Endocrinol Diabetes 2009, 117:336-344.
25. Tell G., Quadrifoglio F., Tiribelli C., Kelley M.R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11:601-620.
26. Tesch G.H., Nikolic-Paterson D.J. Recent insights into experimental mouse models of diabetic nephropathy. Nephron Exp Nephrol 2006, 104:e57-e62.
27. Tesch G.H., Allen T.J. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology 2007, 12:261-266.
28. Thomas M.C., Tikellis C., Burns W.M., Bialkowski K., Cao Z., Coughlan M.T., et al. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol 2005, 16:2976-2984.
29. Wagener F.A.D.T.G., Dekker D., Berden J.H., Scharstuhl A., van der Vlag J. The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 2009, 14:1451-1458.
30. Xiong J.J., Zhang Y., Wang J.L., Bao G.D., Zhang Y., Zhu Z.Y. Silencing of Ref-1 expression by retrovirus-mediated shRNA sensitizes HEK293 cells to hydrogen peroxide-induced apoptosis. Biosci Biotechnol Biochem 2008, 72:3206-3210.
31. Yoon H.J., Moon M.E., Park H.S., Kim H.W., Im S.Y., Lee J.H., et al. Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo. Food Chem Toxicol 2008, 46:710-716.
32. Yoon S.P., Han M.S., Kim J.W., Chang I.Y., Kim H.L., Chung J.H., et al. Protective effects of chitosan oligosaccharide on paraquat-induced nephrotoxicity in rats. Food Chem Toxicol 2011, 49:1828-1833.
33. Yuan W.P., Liu B., Liu C.H., Wang X.J., Zhang M.S., Meng X.M., et al. Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats. World J Gastroenterol 2009, 15:1339-1345.
34. Zaky A., Busso C., Izumi T., Chattopadhyay R., Bassiouny A., Mitra S., et al. Regulation of the human AP-endonuclease (APE/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res 2008, 36:1555-1566.
35. Zhou J., Ahn J., Wilson S.H., Prives C. A role for p53 in base excision repair. EMBO J 2001, 20:914-923.